PMC:3724972 / 22201-22463 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/3724972","sourcedb":"PMC","sourceid":"3724972","source_url":"https://www.ncbi.nlm.nih.gov/pmc/3724972","text":"Temozolomide, an oral alkylating agent typically used in chemotherapeutic treatment of astrocytoma and melanoma, has shown promise as monotherapy [62, 63], and in combination with pasireotide [64], as a treatment for aggressive pituitary adenomas and carcinomas.","tracks":[{"project":"2_test","denotations":[{"id":"23673515-20972839-63233658","span":{"begin":147,"end":149},"obj":"20972839"},{"id":"23673515-22584716-63233659","span":{"begin":151,"end":153},"obj":"22584716"},{"id":"23673515-20496311-63233660","span":{"begin":193,"end":195},"obj":"20496311"}],"attributes":[{"subj":"23673515-20972839-63233658","pred":"source","obj":"2_test"},{"subj":"23673515-22584716-63233659","pred":"source","obj":"2_test"},{"subj":"23673515-20496311-63233660","pred":"source","obj":"2_test"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"2_test","color":"#93b8ec","default":true}]}]}}